Viewing nowCombinationEmpo Duo Tablet 5/1000 mg (Empagliflozin, Metformin Hydrochloride)
Empagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Samchundang Pharmaceutical Co., Ltd.

MFDS item code 202201363 · Approved 2022.04.04 · Insurance code 651206200
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used to enhance blood sugar control in adult patients with type 2 diabetes by assisting with meal planning and exercise, when used in conjunction with empagliflozin and metformin. It is especially crucial for type 2 diabetes patients who have cardiovascular diseases and whose blood sugar is not well controlled, thus requiring careful attention to cardiovascular events as guided by a specialist. This medication helps manage diabetes effectively.
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined according to each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. For patients taking this medicine who do not achieve adequate glycemic control with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current dose of metformin. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their previous doses of empagliflozin and metformin. When this medicine is used concomitantly with a sulfonylurea or insulin, a dose reduction of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Drug Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose of this medicine, take it as soon as you remember. However, do not take twice the dose at one time; if this occurs, skip the missed dose. No dose adjustment is necessary in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who have no other condition that may increase the risk of lactic acidosis. Since the starting dose of metformin in these patients is 500 mg or 850 mg once daily, treatment should be initiated with the individual single-ingredient products of empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered as this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Cautious Administration, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, 2. Patients Who Must Not Take This Medicine, item 2)). In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.
This medication is used for treating diabetes and helps lower blood sugar levels. However, there are several precautions to consider when using this medication: First, the metformin component may rarely cause serious lactic acidosis, which can be dangerous. Lactic acidosis occurs when too much lactic acid builds up in the body and can be very risky; symptoms should be immediately discussed with a doctor. Second, if used alongside insulin or other diabetes medications, hypoglycemia may occur; hence, blood sugar levels must be closely monitored. Third, patients with poor kidney function, acute kidney issues, severe infections, or heart failure should not use this medication. Fourth, if surgery is planned or iodine contrast media tests are to be conducted, the use of this medication should be temporarily suspended before and after the test. Fifth, it is safest for pregnant or breastfeeding women to avoid this medication. Sixth, this medication may elevate the risk of side effects in situations involving dehydration, severe infections, liver dysfunction, or excessive alcohol consumption, so caution is warranted in these scenarios. Seventh, while on this medication, vitamin B12 levels may decrease, thus regular monitoring may be necessary. Finally, it is important to regularly check fluid status, blood pressure, and kidney function during the course of this medication, and report any unusual symptoms to medical personnel immediately. Adhering to precautions and regular check-ups while using this medication is vital.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly sealed container to protect it from air and moisture. It is advisable to keep it at room temperature between 1°C and 30°C. Proper storage will help maintain the medicine's effectiveness.
Biconvex, yellowish-brown oval film-coated tablets
Domestic use - 10 tablets/box [(10 tablets/PTP x 1)], Domestic use - 60 tablets/box [(10 tablets/PTP x 6)], Domestic use - 60 tablets/bottle, Domestic use - 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Samchundang Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.